Hàn Quốc và Mỹ tiến hành vòng đàm phán mới chia sẻ chi phí quân sự

Ngày 3/12, Hàn Quốc và Mỹ đã tiến hành vòng đàm phán thứ 4 về chia sẻ chi phí quân sự duy trì sự hiện diện của Các lực lượng Mỹ tại Hàn Quốc (USFK), trong đó hai nước vẫn bất đồng về khoản chi phí Seoul đóng góp.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh